The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy Transfer
Abstract
The 11-kD protease (PR) encoded by the human immunodeficiency virus 1 (HIV-1) is essential for the correct processing of viral polyproteins and the maturation of infectious virus, and is therefore a target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. To facilitate the identification of novel inhibitors of HIV-1 PR, as well as to permit detailed studies on the enzymology and inhibition of this enzyme, a continuous assay for its activity was developed that was based on intramolecular fluorescence resonance energy transfer (RET). The assay used the quenched fluorogenic substrate 4-(4-dimethylaminophenylazo)benzoic acid (DABCYL)—Ser Gln Asn Tyr Pro Ile Val Gln—5-[(2-aminoethyl)amino]naphthalene-1 sulfonic acid (EDANS), whose peptide sequence is derived from a natural processing site for HIV-1 PR. Incubation of recombinant HIV-1 PR with the fluorogenic substrate resulted in specific cleavage at the Tyr-Pro bond and a time-dependent increase in fluorescence intensity that was linearly related to the extent of substrate hydrolysis. An internally quenched fluorogenic substrate was also designed that was selectively cleaved by the related PR from avian myeloblastosis virus (AMV). The fluorescence quantum yields of the HIV-1 PR and AMV PR substrates in the RET assay increased by 40.0- and 34.4-fold, respectively, per mole of substrate cleaved. Because of its simplicity, rapidity, and precision in the determination of reaction rates required for kinetic analysis, this method offers many advantages over the commonly used high-performance liquid chromatography- or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Fluorescence Energy Transfer as a Spectroscopic Ruler
Stryer, L. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.004131 · Cited by 2,406
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Cornish-Bowden, A. (1974) · Biochemical Journal · doi:10.1042/bj1370143 · Cited by 935
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
Weiss, R. A., & Bernstein, A. (1982) · Cold Spring Harbor Laboratory eBooks · Cited by 828
A structural model for the retroviral proteases
Pearl, L. H., & Taylor, W. R. (1987) · Nature · doi:10.1038/329351a0 · Cited by 598
Crystal structure of a retroviral protease proves relationship to aspartic protease family
Miller, M., Jaskólski, M., Rao, J. K. M., Leis, J., & Wlodawer, A. (1989) · Nature · doi:10.1038/337576a0 · Cited by 343
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier, S., Schmidt, H., Turk, V, & von der Helm, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6612 · Cited by 328
[17] The use of singlet-singlet energy transfer to study macromolecular assemblies
(1978) · Methods in Enzymology · doi:10.1016/s0076-6879(78)48019-x · Cited by 298
Darke, P. L., Nutt, R. F., Brady, S. F., Garsky, V. M., Ciccarone, T. M., Leu, C.-T., Lumma, P. K., Freidinger, R. M., Veber, D. F., & Sigal, I. S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80839-8 · Cited by 268
Crawford, S., & Goff, S. P. (1985) · Journal of Virology · doi:10.1128/jvi.53.3.899-907.1985 · Cited by 246
Katoh, I., Yoshinaka, Y., Rein, A., Shibuya, M., Odaka, T., & Oroszlan, S. (1985) · Virology · doi:10.1016/0042-6822(85)90161-8 · Cited by 233
Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
Katoh, I., Yasunaga, T., Ikawa, Y., & Yoshinaka, Y. (1987) · Nature · doi:10.1038/329654a0 · Cited by 181
Human immunodeficiency virus protease
Darke, P. L., Leu, C. T., Davis, L. J., Heimbach, J. C., Diehl, R. E., Hill, W. S., Dixon, R. A., & Sigal, I. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94177-3 · Cited by 174
Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases
Richards, A. D., Roberts, R., Dunn, B. M., Graves, M. C., & Kay, J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81251-7 · Cited by 166
Kräusslich, H. G., Ingraham, R. H., Skoog, M. T., Wimmer, E., Pallai, P. V., & Carter, C. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.807 · Cited by 166
Peptide substrates and inhibitors of the HIV-1 protease
Moore, M. L., Bryan, W. M., Fakhoury, S. A., Magaard, V. W., Huffman, W. F., Dayton, B. D., Meek, T. D., Hyland, L., Dreyer, G. B., Metcalf, B. W., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90008-9 · Cited by 161
Pseudomonas aeruginosa elastase. Development of a new substrate, inhibitors, and an affinity ligand.
Nishino, N., & Powers, J. C. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85724-1 · Cited by 146
Intramolecularly quenched fluorogenic substrates for hydrolytic enzymes
Yaron, A., Carmel, A., & Katchalski‐Katzir, E. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90210-0 · Cited by 129
Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease.
Billich, S., Knoop, M.-T., Hansen, J., Strop, P., Sedláček, J., Mertz, R., & Moelling, K. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81300-5 · Cited by 126
Synthetic peptides as substrates and inhibitors of a retroviral protease.
Kotler, M., Katz, R. A., Danho, W., Leis, J. P., & Skalka, A. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4185 · Cited by 84
Oroszlan, S. I., & Copeland, T. D. (1985) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-70113-9_14 · Cited by 53
Cited by
Light-Directed, Spatially Addressable Parallel Chemical Synthesis
Fodor, S. P. A., Read, J. L., Pirrung, M. C., Stryer, L., Lu, A. T., & Solas, D. (1991) · Science · doi:10.1126/science.1990438 · Cited by 2,696
The LightCycler TM : A Microvolume Multisample Fluorimeter with Rapid Temperature Control
Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., & Balis, U. J. (1997) · BioTechniques · doi:10.2144/97221pf02 · Cited by 893
Quantitative Fluorescence Resonance Energy Transfer Measurements Using Fluorescence Microscopy
Gordon, G. W., Berry, G., Liang, X. H., Levine, B., & Herman, B. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77976-7 · Cited by 854
Ton-That, H., Liu, G., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12424 · Cited by 567
Semi-wet peptide/protein array using supramolecular hydrogel
Kiyonaka, S., Sada, K., Yoshimura, I., Shinkai, S., Kato, N., & Hamachi, I. (2004) · Nature Materials · doi:10.1038/nmat1034 · Cited by 560
Metadata
- Authors
- Matayoshi, E. D., Wang, G. T., Krafft, G. A., & Erickson, J.
- Venue
- Science
- Published
- 1990-02-23
- Volume
- 247
- Issue
- 4945
- Pages
- 954-958
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2092093169
- Cited by
- 592
- References
- 24
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.